tiprankstipranks
Eupraxia Pharmaceuticals (TSE:EPRX)
TSX:EPRX
Canadian Market

Eupraxia Pharmaceuticals (EPRX) Income Statement

Compare
22 Followers

Eupraxia Pharmaceuticals Income Statement

Last quarter (Q3 2024), Eupraxia Pharmaceuticals's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Eupraxia Pharmaceuticals's net income was C$-5.94M. See Eupraxia Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -209.91KC$ -193.27KC$ -111.53KC$ -116.81KC$ -201.94K
Operating Expenses
C$ 37.92MC$ 23.20MC$ 18.68MC$ 2.25MC$ 6.16M
Depreciation and Amortization
C$ 209.91KC$ 193.27KC$ 111.53KC$ 116.81KC$ 201.94K
EBITDA
C$ -37.40MC$ -22.14MC$ -21.96MC$ -2.01MC$ -5.94M
Operating Income
C$ -36.90MC$ -22.63MC$ -20.87MC$ -2.25MC$ -6.15M
Other Income/Expenses
C$ -2.29MC$ -64.07KC$ -5.46MC$ -1.76MC$ -1.08M
Pretax Income
C$ -39.18MC$ -23.92MC$ -23.37MC$ -4.01MC$ -7.24M
Net Income
C$ -37.39MC$ -23.26MC$ -22.99MC$ -4.00MC$ -7.18M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -1.58C$ -1.21C$ -1.61C$ -0.31C$ -0.56
Diluted EPS
C$ -1.58C$ -1.21C$ -1.61C$ -0.31C$ -0.56
Weighted Average Shares Outstanding
24.15M 19.29M 14.24M 12.87M 12.87M
Weighted Average Shares Outstanding (Diluted)
24.15M 19.29M 14.24M 12.87M 12.87M
Currency in CAD

Eupraxia Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis